Simultaneous Determination of Dabigatran, Rivaroxaban, Apixaban, and Warfarin in Human Blood Serum by HPLC-MS/MS for Therapeutic Drug Monitoring
Crossref DOI link: https://doi.org/10.1007/s11094-022-02633-y
Published Online: 2022-05-07
Published Print: 2022-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rodina, T. A.
Melnikov, E. S.
Aksenov, A. A.
Belkov, S. A.
Sokolov, A. V.
Prokof’ev, A. B.
Ramenskaya, G. V.
Text and Data Mining valid from 2022-05-01
Version of Record valid from 2022-05-01
Article History
Received: 26 November 2018
First Online: 7 May 2022